Carpenter J A, Gibbins R J, Marshman J A
J Stud Alcohol Suppl. 1975 Nov;7:54-139. doi: 10.15288/jsas.1975.s7.54.
Five experiments were conducted to study the effects of alcohol and meprobamate, administered singly and in combination, at doses up to 1.20 g of alcohol per kg of body weight and up to 30 mg of meprobamate per kg. Most of the 158 men were of college age (range, 21-49). In all experiments it appeared to the subjects that both drugs were administered, alcohol as a 25% solution in orange juice and meprobamate as 10 tablets. One hour after the men took the meprobamate they had 1 hr to drink the beverage. Before and at 1/2 hr intervals after administration of the drugs blood samples were taken and behavioral response measured by means of a visual-motor coordination tracking task (Stressalyzer). An experimental session lasted 6 hr. In Experiment I (E-I) each of 12 men was tested on 2 days, after 0, 1.00 or 1.20 g of alcohol per kg and 0 or 25 mg of meprobamate per kg. In Experiment II (E-II) 56 men were tested (8 per group) after 0, 5, 10, 15, 20, 25 or 30 mg of meprobamate per kg and alcohol placebo. In Experiment III (E-III) 40 men were tested (8 per group) after 0, 0.25, 0.50, 0.75, or 1.00 g of alcohol per kg and meprobamate placebo. In Experiment IV (E-IV) 25 men (5 per group) received meprobamate 3 times a day (total daily dosage, 0, 7, 14, 21 or 28 mg per kg) for 12 days. On days 8 to 12 all subjects drank alcohol, as in E-III. In Experiment V (E-V) 25 subjects (5 per group) were tested on 5 days, drinking each day the same doses of alcohol as in E-III and all received the same doses of meprobamate as in E-IV.
进行了五项实验,以研究酒精和眠尔通单独及联合使用的效果,酒精剂量最高可达每千克体重1.20克,眠尔通剂量最高可达每千克30毫克。158名男性大多为大学年龄(范围为21至49岁)。在所有实验中,对受试者而言,两种药物都像是被给予了,酒精是以橙汁中25%的溶液形式,眠尔通是以10片药片的形式。男性服用眠尔通1小时后,有1小时时间饮用该饮料。在给药前以及给药后每隔半小时采集血样,并通过视觉运动协调追踪任务(应激分析仪)测量行为反应。一个实验环节持续6小时。在实验I(E-I)中,12名男性每人在2天内接受测试,分别给予每千克0、1.00或1.20克酒精以及每千克0或25毫克眠尔通。在实验II(E-II)中,56名男性(每组8人)在给予每千克0、5、10、15、20、25或30毫克眠尔通以及酒精安慰剂后接受测试。在实验III(E-III)中,40名男性(每组8人)在给予每千克0、0.25、0.50、0.75或1.00克酒精以及眠尔通安慰剂后接受测试。在实验IV(E-IV)中,25名男性(每组5人)每天服用眠尔通3次(每日总剂量为每千克0、7、14、21或28毫克),持续12天。在第8至12天,所有受试者像在E-III中那样饮用酒精。在实验V(E-V)中,25名受试者(每组5人)在5天内接受测试,每天饮用与E-III中相同剂量的酒精,并且全部接受与E-IV中相同剂量的眠尔通。